Neonates who receive extracorporeal membrane oxygenation (ECMO) for intractable respiratory failure experience lung injury lasting into later childhood.
Guidance from ROTEM analyses facilitates hemostasis management after neonatal CPB. Circuit miniaturization with transfusion-free CPB is associated with acceptable changes in ROTEM in most patients, and allows sufficient hemostasis without any HD transfusions in most patients.
